EditorialPublished 30 Oct 2024
Pharmacogenomics in Cancer Treatment Tailoring Therapy for Better Outcomes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmacogenomics, the study of how genes affect a person’s response to drugs, has emerged as a pivotal field in cancer treatment. By integrating genetic profiling with therapeutic strategies, healthcare providers can tailor treatments to individual patients, potentially improving efficacy and reducing adverse effects. This article reviews the current state of pharmacogenomics in cancer therapy, examining its role in personalized medicine, the challenges in implementation, and the future directions of this evolving field. By highlighting key studies and advancements, we underscore the transformative potential of pharmacogenomics in enhancing cancer treatment outcomes.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Science Journal
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Saskia Winterfeld”
